| __timestamp | Blueprint Medicines Corporation | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 15411924 |
| Thursday, January 1, 2015 | 48588000 | 22593274 |
| Friday, January 1, 2016 | 81131000 | 33173050 |
| Sunday, January 1, 2017 | 144687000 | 62224159 |
| Monday, January 1, 2018 | 243621000 | 95607434 |
| Tuesday, January 1, 2019 | 331450000 | 221269028 |
| Wednesday, January 1, 2020 | 326860000 | 400745069 |
| Friday, January 1, 2021 | 601033000 | 580520000 |
| Saturday, January 1, 2022 | 477419000 | 663366000 |
| Sunday, January 1, 2023 | 427720000 | 755113687 |
| Monday, January 1, 2024 | 341433000 |
In pursuit of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, argenx SE and Blueprint Medicines Corporation have been at the forefront of this transformative journey. From 2014 to 2023, both companies have significantly ramped up their R&D spending, reflecting their commitment to pioneering new therapies.
Blueprint Medicines Corporation started with a modest investment in 2014, but by 2021, their R&D expenses had surged by nearly 1,800%, peaking at over 600 million dollars. Meanwhile, argenx SE, with a more gradual increase, saw its R&D spending grow by an impressive 4,800% over the same period, reaching approximately 755 million dollars in 2023.
This data underscores the relentless pursuit of innovation in the biotech sector, with both companies striving to bring groundbreaking treatments to market.
Analyzing R&D Budgets: argenx SE vs BeiGene, Ltd.
R&D Insights: How argenx SE and United Therapeutics Corporation Allocate Funds
Research and Development: Comparing Key Metrics for argenx SE and Insmed Incorporated
Research and Development Expenses Breakdown: argenx SE vs Viatris Inc.
Research and Development Expenses Breakdown: argenx SE vs Grifols, S.A.
argenx SE vs ImmunityBio, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: argenx SE vs Ligand Pharmaceuticals Incorporated
R&D Spending Showdown: BeiGene, Ltd. vs Blueprint Medicines Corporation
Research and Development Investment: Blueprint Medicines Corporation vs Ionis Pharmaceuticals, Inc.
Blueprint Medicines Corporation or Vericel Corporation: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs Iovance Biotherapeutics, Inc.
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs MannKind Corporation